Join me in Montréal on 12 May 2025 for two half day workshops on health economic evaluation and decision analytic modeling. I'll be co-teaching these alongside Dr Jason Guertin. Both workshops will be taught in English and French. Visit to register.

My 'Framework for the Fair Pricing of Medicines' has just been published as a Leading Article by Pharmacoeconomics. This framework proposes a number of advancements to existing approaches for specifying a 'cost-effectiveness threshold' for new medicines.

RT @AnkurFactorial: In @MedDecMak , @mikepaulden @jinyizhu_ @tara_lavelle Jim Hammitt and I looked at trends in author-reported cost-effect….

RT @EdCFWilson: #Health #economics thought for the day:. Incremental analysis with multiple comparators is a pain and easy to get wrong. M….

I agree. List prices in other countries do not reflect the value that drugs provide to Canadian patients, and it is inexplicable that Canadian drug price regulation will remain limited to this outdated consideration. Canada has the means and expertise to do better. @PMPRB_CEPMB.

RT @jamesfomahony: Sometimes I engage with established researchers and I'm amazed how rigid their thinking has become. Contrast that with….

RT @AmyKaler: Hello @UAlberta & @BFlanaganUofA. Today's the first class meeting one of my courses since the commitment to a campus mask man….

RT @AmyKaler: @UAlberta you committed to retaining campus mask mandate thru end of Winter 2022. Staff & students made decisions on in-perso….

RT @uasupresident: It's a sad day for Alberta to see these massive, disgraceful tuition increases at both our largest universities. It's f….

RT @uasupresident: Seen on Reddit today-- a heartbreaking reminder of how political games cause pain to real people, especially around mask….

Establishing reasonable prices for new oncology drugs is an extremely difficult task, one that requires input from stakeholders with a broad range of expertise. Publishing arrogant and ill-informed editorials that disparage an entire discipline does nothing to advance this. [4/4].

Nor is it acknowledged that recent international empirical estimates of the health opportunity cost associated with marginal public health care spending are nowhere close to CAD$250,000 per QALY, and instead are much closer to CADTH's current CAD$50,000 per QALY threshold. [3/4].

In all seriousness, this is a remarkably poor article that does a disservice to readers of @CurrentOncology. Nowhere is it acknowledged that high prices for drugs can harm the health of Canadians - including cancer patients - given constrained public health care resources. [2/4].

I still cherish the magic wand I received when I graduated as a health economist. But magic can be dangerous. In this case, a careless magician has caused all qualified peer reviewers to disappear, and the credibility of the journal to vanish. [1/4]

RT @PECjournal: 10th most read paper in 2021 from @PECjournal is a paper by @MccabeCJM @mikepaulden @PeterHall001 et al. on probabilistic 1….

RT @uasupresident: I am profoundly disappointed to see a $52M cut to #ualberta in Budget 2022. This will cause pointless pain for students….

RT @CanPaedSociety: 1/7 Lifting mask mandates and other public health measures while so few children are vaccinated puts them disproportion….

RT @gregbd: Read this letter from public health educators to @jkenney who are condemning the elimination of Heath protections, let’s make t….

RT @LeylaDAsadi: Public health experts from @UAlberta are also speaking out against the removal of public health protections. We have man….

RT @ehyshka: U of A public health experts call Alberta plan to phase out all COVID-19 restrictions 'reckless' | CBC News .